Home
TimeZone
   
Currency
   
Language
  HOME   STOCK MARKETS PORTFOLIO WATCHLIST ALERTS INDICES CONVERTER IR SERVICES MORE


  Press releases - Corporate Sites
Select Stock Market:
All Abu Dhabi Amsterdam BATS Bombay Brussels Burgundy Chi-X Copenhagen Dubai Dublin Frankfurt
Hanoi Helsinki HoChiMinh Hong Kong Iceland Lisbon London Madrid Milan Moscow Moscow Classica
Nasdaq NSE (India) NYSE NYSE MKT Oslo Paris Riga Shanghai Stockholm Tallinn Tokyo
Toronto TSX Venture Tunis USOTC Warsaw Vienna Vilnius XETRA Zurich
Select Period:                 Order by:
All Today Yesterday Last week Last month Date Company
 


2024-06-03 
EISAI CO., LTD. : EISAI NAMED TO LIST OF THE TIME 100 MOST INFLUENTIAL COMPANIES
2024-06-03 
EISAI CO., LTD. : Eisai Announces Status Relating to Acquisition of Own Shares Acquisition of own shares pursuant to the provision of its Articles of Incorporation in accordance with Article 459, paragraph 1 of the Companies Act
2024-06-03 
EISAI CO., LTD. : EISAI STRENGTHENS VENTURE INVESTMENT BUSINESS AIMED AT ACCELERATING DRUG DISCOVERY INNOVATION AND ESTABLISHMENT OF ECOSYSTEM PLATFORM
2024-06-02 
DAIICHI SANKYO CO., LTD. : ENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy (463.7KB)
2024-05-30 
TOYOBO CO., LTD. : Notice of the 166th Annual General Meeting of Shareholders
2024-05-29 
KONAMI GROUP CORPORATION : Shareholders Situation:As of March 31, 2024
2024-05-29 
KONAMI GROUP CORPORATION : NOTICE OF THE 52ND ORDINARY GENERAL MEETING OF SHAREHOLDERS
2024-05-27 
AJINOMOTO CO., INC. : Ajinomoto Announces Comprehensive Nutritional Support for TEAM JAPAN at Olympic and Paralympic Games Paris 2024 – Harnessing the Power of Umami and “AminoScience” to Boost Athletes’ Performance and Well-being
2024-05-27 
DAIICHI SANKYO CO., LTD. : Datopotamab Deruxtecan Showed Clinically Meaningful Overall Survival Improvement Versus Chemotherapy in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer in TROPION-Lung01 Phase 3 Trial(173.2KB)
2024-05-27 
EISAI CO., LTD. : “LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in South Korea
2024-05-27 
TOYOBO CO., LTD. : Newly developed “ReCrysta™,” a PET film for shrink labels, receives recognition for APR Design® for Recyclability



   2024      2023      2022      2021      2020      2019      2018      2017      2016      2015      2014      2013      2012      2011      2010      2009      2008      2007      2006      2005      2004      2003      2002      2001      2000  
Back